An insulin sliding scale assigns a fixed insulin dose based on the current blood glucose value at pre-meal or bedtime checks — for example, 2 units at 150 to 200 mg/dL, 4 units at 201 to 250, and so on. The approach is reactive and historically common but is discouraged by the American Diabetes Association as the sole long-term outpatient regimen because it produces wider glucose swings and worse A1C than basal-bolus therapy. Sliding scale still has a legitimate role in hospitals (combined with scheduled basal insulin) and during short transitional periods, and its math is the foundation for the modern individualized “correction” layer of basal-bolus dosing.
What a Sliding Scale Looks Like
| Blood Glucose (mg/dL) | Insulin Dose (units, rapid analog) |
|---|---|
| <70 | Treat hypoglycemia, hold insulin, recheck |
| 70–150 | 0 units |
| 151–200 | 2 units |
| 201–250 | 4 units |
| 251–300 | 6 units |
| 301–350 | 8 units |
| 351–400 | 10 units; notify clinician |
| >400 | Notify clinician; check ketones |
The example above is a common starter or “mid-sensitivity” scale. Scales are categorized as low, mid, or high sensitivity — more units per BG range for the high-sensitivity scale (used in insulin-resistant patients), fewer units for low-sensitivity (used in older or thin patients).
How It Differs From Basal-Bolus
| Feature | Sliding Scale Alone | Basal-Bolus |
|---|---|---|
| Background insulin | None | Long-acting basal once or twice daily |
| Meal coverage | None (only reacts after meal) | Anticipatory bolus per meal carbs |
| Individualization | Fixed chart | Insulin-to-carb ratio and correction factor |
| Hypoglycemia risk | Variable; often higher in inpatient studies | Predictable; lower with structured dosing |
| A1C achievable | Higher than target | Best for injection therapy |
| Best fit | Inpatient correction, transitions | Standard outpatient therapy |
For the full comparison, see basal-bolus insulin regimen and our overview of insulin types comparison.
Why ADA Discourages Standalone Outpatient Use
- It only treats hyperglycemia after it occurs rather than preventing it before meals
- It does not provide steady basal insulin to suppress hepatic glucose output overnight
- It encourages glucose roller-coaster patterns — high then low then high — that worsen A1C variability
- It promotes the misconception that BG-only dosing is sufficient
- Randomized inpatient trials (RABBIT 2 and others) consistently favor basal-bolus over sliding scale
- The ADA Standards of Care state that sliding scale as monotherapy has “no role” in modern outpatient diabetes management
Where Sliding Scale Still Has a Role
- Hospital inpatient management — combined with scheduled basal insulin and meal boluses, the sliding “correction” layer addresses glucose above target without becoming the sole therapy.
- Transition off intravenous insulin — after DKA or surgery, the patient often goes through a sliding-scale phase for 1 to 2 days before regular subcutaneous regimens are established.
- Short-term steroid courses — when prednisone is started for 5 to 7 days, a temporary scale can manage spikes until tapering.
- Sick days at home — for people on premix or basal-only regimens, a supplemental scale can correct unusually high readings during illness.
- Late initiation in cognitively limited patients — when carb counting is not feasible and family supervises meals, a simplified scale on top of basal may be acceptable.
Modern Replacement — The Individualized Correction Scale
The math behind a sliding scale survives in modern care as the correction factor — a personalized number that says how much 1 unit of insulin lowers your blood glucose. Built using the 1800 Rule (1800 divided by total daily dose), the correction factor lets you compute exactly the right correction units for your premeal BG, rather than reading from a one-size-fits-all chart.
| Approach | Calculation | Example for BG 220, TDD 50 |
|---|---|---|
| Mid-sensitivity sliding scale | From chart: 201–250 → 4 units | 4 units |
| Correction factor (1800 Rule) | CF = 1800/50 = 36; (220 − 110) ÷ 36 = 3.1 | 3 units |
| Correction + meal bolus | Above 3 units + meal bolus per carbs | 3 + (carbs ÷ I:C) |
Inpatient Use — The Practical Framework
Most hospital protocols use three components in parallel:
- Scheduled basal — usually glargine once daily at a dose calculated from prior outpatient use or weight (about 0.2 to 0.3 u/kg)
- Scheduled nutritional bolus — given before meals or split across continuous tube feeds
- Correction (sliding) scale — applied at each premeal or every 4 to 6 hours if NPO, layered on top of the scheduled doses
If a patient consistently needs >20 percent of TDD as correction, the basal and bolus components are increased so the patient does not chronically run high.
Hypoglycemia and Other Risks
- Stacking — repeated corrections within 3 hours can cause delayed hypoglycemia from overlapping insulin action
- Missed meals after a fixed dose — though sliding scale itself does not cover meals, mistakes happen during transitions
- Iatrogenic hypoglycemia in older or thin patients dosed from a standard scale
- Hyperglycemic carryover overnight when scale is only applied at meals
- Burnout — the appearance of simplicity masks suboptimal control over months
Historical Context
Sliding scales date back to the 1930s as a pragmatic workaround for hospitalized patients. The first major published critique was Skyler in 1986, who argued the approach was outdated even then. By the 2000s, randomized inpatient trials such as RABBIT 2 confirmed basal-bolus superiority. ADA and Endocrine Society guidelines now explicitly recommend against standalone sliding scale outside the inpatient correction context.
How to Transition Off a Sliding Scale
- Calculate the average daily insulin requirement over the last 3 to 5 days, including sliding-scale doses.
- Set 50 percent as a long-acting basal at bedtime — typically glargine or degludec.
- Split 50 percent across meals as a rapid analog. Start with even thirds; adjust per meal carbs.
- Replace the sliding scale with a correction factor calculated from the new total daily dose (1800 Rule).
- Review fasting and post-meal glucose for 1 to 2 weeks and refine basal, bolus, and correction factor.
- Add a CGM if not already in use to make titration safer.
Pros and Cons at a Glance
| Pros (When Appropriate) | Cons |
|---|---|
| Simple, no math | Reactive, not anticipatory |
| No carb counting required | Wider glucose swings |
| Useful in inpatient, transitional contexts | Higher A1C versus basal-bolus |
| Easy to teach hospital staff | Discouraged by ADA as standalone outpatient therapy |
| Familiar to many clinicians | Misses underlying basal need |
External Sources
For evidence on inpatient sliding scale versus basal-bolus, see the RABBIT 2 randomized trial. For consensus on its role today, see the ADA Standards of Care 2024 hospital diabetes management section.
The Bottom Line
An insulin sliding scale prescribes a fixed insulin dose by current blood glucose level — simple, familiar, and reactive. It is appropriate as a correction layer in hospitals and during short transitional periods, but it is discouraged by ADA as standalone outpatient therapy because it produces wider glucose swings and worse A1C than basal-bolus regimens. The modern individualized correction factor is the preferred replacement. If you are still on a sliding scale alone at home, talk with your clinician about transitioning to a basal-bolus or premix regimen with an individualized correction layer for tighter control and fewer extremes.
